Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiangdong Lv

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
The Journal of Clinical Investigation|February 27, 2018
Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancerNa Zhao, Jin Cao, Longyong Xu, et al.
Science (New York, N.Y.)|September 7, 2023
Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitorsXiangdong Lv, Xuan Lu, Jin Cao, et al.
Cell|October 17, 2024
IRE1α silences dsRNA to prevent taxane-induced pyroptosis in triple-negative breast cancerLongyong Xu, Fanglue Peng, Qin Luo, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
The Journal of Clinical Investigation|February 27, 2018
Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancerNa Zhao, Jin Cao, Longyong Xu, et al.
Science (New York, N.Y.)|September 7, 2023
Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitorsXiangdong Lv, Xuan Lu, Jin Cao, et al.
Cell|October 17, 2024
IRE1α silences dsRNA to prevent taxane-induced pyroptosis in triple-negative breast cancerLongyong Xu, Fanglue Peng, Qin Luo, et al.
Pageof 3